A cutting-edge genetic test can rapidly detect and identify almost any kind of disease-causing microorganism in the human ...

In line with the restructuring initiative, 23andMe is looking for strategic opportunities for its pipeline assets, including ...

Ibuprofen counters problems caused by mutations in the MAN1B1 gene, fruit fly tests show. Early results in three children are ”fairly positive.” ...

Increased awareness of genetic testing’s role in disease prevention is driving market growth. Saudi Arabia's genetic testing ...

23andMe currently lists two assets in early-stage testing. First ... The dual-mechanism drug targets ULBP6, which is secreted ...

The genetics company is closing a unit that was once seen as core to its future.

A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer ...

focusing instead on selling genetic tests to consumers and using the resulting data for research. In closing its therapeutics ...

Elevidys sales have increased since the FDA made a controversial choice to expand the therapy's use. Meanwhile, Sarepta is ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

Scientists investigated how an inherited genetic variation common among East Asians contributes to drug resistance in cancer cells, driving more aggressive cancer growth. The team trialled a precision ...